ASTRAZENECA PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 381.0%
Tue, 12 Feb

ASTRAZENECA PHARMA has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m1,2851,6142,15233.4%67.4%
Other incomeRs m2734354.2%29.2%
TurnoverRs m1,3121,6472,18732.8%66.6%
ExpensesRs m1,3941,4661,74318.9%25.1%
Gross profitRs m-108148409176.9%
DepreciationRs m3737382.9%1.4%
InterestRs m0000.0%0.0%
Profit before taxRs m-118144406181.1%
TaxRs m-1553115116.5%
Profit after taxRs m-10491291218.6%
Gross profit margin%-8.49.119.0
Effective tax rate%12.436.828.3
Net profit margin%-7.95.513.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 67.4% on a year-on-year (YoY) basis. The expenses were up by 25.1% YoY during the same period.
  • The company's operating profit declined by 478.8% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 19.0% in 3QFY19 as against 8.4% in 3QFY18.
  • Depreciation charges increased by 1.4% and finance costs increased by 0.0% YoY, respectively.
  • Other income increased by 29.2% YoY during the quarter.
  • Net profit for the quarter increased by 381.0% YoY. Net profit margins during the quarter increased from -7.9% in 3QFY18 to 13.3% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 33.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 18.9% QoQ during the same period.
  • The company's operating profit increased by 176.9% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 19.0% in 3QFY19 as against 9.1% in 2QFY18.
  • Net profit for the quarter increased by 218.6% QoQ, while net profit margins increased from 5.5% in 2QFY18 to 13.3% in 3QFY19.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters, please visit here.

ASTRAZENECA PHARMA Share Price Performance

Over the last one year, ASTRAZENECA PHARMA share price has moved up from Rs 1,050.4 to Rs 1,847.0, registering a Gain of Rs 796.6 or around 75.8%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,718.3 (down 0.0%). Over the last one year it has moved down from 14,517.2 to 13,718.3, a gain of 799 points (down 5.5%).

Overall, the S&P BSE SENSEX is up 6.1% over the year.

Current Valuations

At the current price of Rs 1,847.0, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 96.5 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 26.9 times.